Success Stories

Success Stories

The Coulter Program at the University of Michigan has provided translational research funding leading to several successful commercial exits, in the form of venture capital backed start-up companies and technology licensing to existing companies.

Since program inception in 2006 through 2023, Coulter has funded 66 projects with Evolve full funding and since the C3i/Enlighten program inception in 2015, Coulter has taken 49 project proposal teams through the Enlighten/C3i program.

Results of Coulter funding and support efforts have led to:

  • 20 Startup formations
  • 14 Startups that raised Angel or Venture Capital financing
  • 5 License deals to existing companies
  • $362 million in Angel or Venture Capital raised

Here are a few of our success stories:

Histosonics
Akadeum Life Sciences
Inrad
Endovascular Engineering
Remix
TRS Tissue Regeneration Systems
AVS Amplitude Vascular Systems, Inc.
New Vital Signs
Baxter
Natus
Recens Medical
Neuable
Optofluidic Bioassay, LLC
Auricle
BLue Arbor Technologies